关键词: COVID-19 CVD, Cardiovascular disease Health services NCD, Non-communicable disease Noncommunicable diseases SEA, South East Asia South East Asia WHO, World Health Organization

来  源:   DOI:10.1016/j.lansea.2022.04.006   PDF(Pubmed)

Abstract:
UNASSIGNED: COVID-19 has had a profound impact on the health systems of the 11 countries of the WHO South East Asia Region. We conducted a systematic review of studies that used quantitative and comparative approaches to assess the impact of the pandemic on the service provision of four noncommunicable diseases (NCDs) (cancer, cardiovascular disease, chronic respiratory diseases, and diabetes) in the region.
UNASSIGNED: A systematic search was conducted in PubMed, Embase, MedRxiv, and WHO COVID-19 databases in December 2021. The quality of studies was evaluated using the Joanna Briggs Institute Critical Appraisal Checklist and the ROBINS-I risk of bias tool. A narrative synthesis was conducted following the \'synthesis without meta-analysis\' reporting guidelines.
UNASSIGNED: Two review authors independently screened 5,397 records with 31 studies included, 26 which were cross-sectional studies. Most studies (n=24, 77%) were conducted in India and 19 (61%) were single-site studies. Compared to a pre-pandemic period, 10/17 cancer studies found a >40% reduction in outpatient services, 9/14 cardiovascular disease found a reduction of 30% or greater in inpatient admissions and 2 studies found diagnoses and interventions for respiratory diseases reduced up to 78.9% and 83.0%, respectively. No eligible studies on the impact of COVID-19 on diabetes services were found.
UNASSIGNED: COVID-19 has substantially disrupted the provision of essential health services for NCDs in the WHO South East Asia Region, particularly cancer and cardiovascular disease. This is likely to have serious and potentially long-term downstream impacts on health and mortality of those living with or at risk of NCDs in the region.
UNASSIGNED: This work was supported by the WHO Sri Lanka Country Office.
摘要:
COVID-19对世卫组织东南亚区域11个国家的卫生系统产生了深远的影响。我们对使用定量和比较方法的研究进行了系统回顾,以评估大流行对四种非传染性疾病(NCDs)服务提供的影响(癌症,心血管疾病,慢性呼吸系统疾病,和糖尿病)在该地区。
在PubMed中进行了系统搜索,Embase,MedRxiv,和世卫组织COVID-19数据库于2021年12月发布。使用JoannaBriggs研究所关键评估清单和ROBINS-I偏倚风险工具评估研究质量。按照“无荟萃分析的综合”报告指南进行叙述性综合。
两位综述作者独立筛选了5397条记录,包括31项研究,26个是横断面研究。大多数研究(n=24,77%)在印度进行,19(61%)是单中心研究。与大流行前相比,10/17癌症研究发现,门诊服务减少了>40%,9/14心血管疾病在住院患者中减少了30%或更多,2项研究发现呼吸系统疾病的诊断和干预措施减少了78.9%和83.0%,分别。没有发现关于COVID-19对糖尿病服务影响的合格研究。
COVID-19严重扰乱了世卫组织东南亚区域非传染性疾病基本卫生服务的提供,特别是癌症和心血管疾病。这可能会对该区域非传染性疾病患者的健康和死亡率产生严重和潜在的长期影响。
这项工作得到了世卫组织斯里兰卡国家办事处的支持。
公众号